Clinical Trial Details

EORTC-30867

Back to Clinical Trials Database

PHASE II STUDY OF Epirubicin IN ADVANCED TCC OF THE URINARY TRACT FOR PATIENTS RESISTANT TO OR INELIGIBLE FOR FIRST LINE CHEMOTHERAPY

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 15-Jun-1986
Date Step1 close: 15-Sep-1987
Date Step2 close: 01-Aug-1988
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 23
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/
NCT number